Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
2(18%)
Results Posted
50%(3 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
6
55%
Ph phase_1
1
9%
Ph early_phase_1
1
9%
Ph phase_2
1
9%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
1(11.1%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(6)
Terminated(1)
Other(2)

Detailed Status

Completed6
unknown2
Recruiting1
Terminated1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
85.7%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (11.1%)
Phase 11 (11.1%)
Phase 21 (11.1%)
N/A6 (66.7%)

Trials by Status

recruiting19%
completed655%
terminated19%
unknown218%
active_not_recruiting19%

Recent Activity

2 active trials
Showing 5 of 11
completednot_applicable

Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study

NCT07713654
recruitingnot_applicable

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

NCT04692675
terminatednot_applicable

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies

NCT02971995
completedphase_1

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

NCT03388619
completedearly_phase_1

Assessment of Renal Function by Multiparametric MRI

NCT06407375
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT07713654Not Applicable

Tumor Heterogeneity of Renal Tumors Assessed by Multiparametric MRI With Direct Radiological-histopathological Correlation: an Explorative Study

Completed
NCT04692675Not Applicable

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Recruiting
NCT02971995Not Applicable

Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate Biopsies

Terminated
NCT03388619Phase 1

Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy Radiotherapy

Completed
NCT06407375Early Phase 1

Assessment of Renal Function by Multiparametric MRI

Completed
NCT02430480Phase 2

Using Multiparametric MRI to Evaluate Intraprostatic Tumor Responses and Androgen Resistance Patterns in Newly Diagnosed Prostate Cancer

Completed
NCT06640153

MRI and CT in Gastroesophageal Junction or Upper Gastric Adenocarcinoma

Active Not Recruiting
NCT03730324Not Applicable

Predicting Prostate Biopsy Results With Biomarkers and mpMRI.

Completed
NCT03436550

Assessment of Portal Hypertension With Multiparametric MRI

Completed
NCT03960112Not Applicable

Multicentric Evaluation of the True Negative Predictive Value of Multiparametric MRI for the Detection of Prostate Cancer Using Cystoprostatectomy Specimen as Reference

Unknown
NCT03914001Not Applicable

Comprehensive Multiparametric Magnetic Resonance Imaging After Transurethral Resection of Non Muscle-invasive Bladder Tumor; Can it Replace Second Look Biopsy? A Prospective Study

Unknown

All 11 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
11